NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
City of Hope Medical Center
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
New Approaches to Neuroblastoma Therapy Consortium
Barbara Ann Karmanos Cancer Institute
St. Anna Kinderkrebsforschung
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
NYU Langone Health
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Duke University
University of Kentucky
Memorial Sloan Kettering Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
Fred Hutchinson Cancer Center